Psychopharmacology

The Psychopharmacology Conference, hosted by Massachusetts General Hospital and Harvard Medical School, is celebrating its 50th Annual event at The Westin Copley Place in Boston. This conference has been instrumental in advancing psychiatric education and care over the past five decades, focusing on the treatment and understanding of mental health conditions. In 2026, attendees will reflect on the legacy of the conference while looking forward to new advancements in the field. The program promises to uphold a commitment to clinical depth, scientific rigor, and practical application, with sessions addressing critical topics such as Depression, Bipolar Disorder, and Anxiety, alongside Integrative Approaches and Pharmacologic Innovations.Participants can benefit from Curbside Consultations, which provide informal opportunities to engage one-on-one with faculty members across various specialties. These consultations facilitate discussions on nuanced clinical questions and challenging cases in a supportive environment. Additionally, a full virtual attendance option is available, ensuring accessibility for those unable to attend in person. This eco-friendly alternative also includes ticketed events and seminars for Friday and Saturday evenings as part of the virtual registration. Notably, the Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition, will be offered, drawing on over 80 years of clinical experience aimed at assisting participants in preparing for board certification and recertification exams.This conference caters to a diverse audience, including psychiatrists, psychologists, general and family practice physicians, psychiatric nurses, physician assistants, nurse practitioners, and social workers. By participating, attendees will enhance their skills in identifying evidence-based therapies for various psychiatric disorders, including unipolar, bipolar, treatment-resistant, and post-partum depression. The program will also delve into the neurobiology and treatment approaches for addiction, anxiety, schizophrenia, and mood disorders, as well as cover the course and treatment of psychiatric disorders during pregnancy and menopause. Attendees will analyze drug interactions and pharmacotherapy for adult ADHD and geriatric disorders, while also exploring newer strategies for treating chemical dependence and evidence-based treatment for psychiatric illnesses. With Massachusetts General Hospital's Psychiatry Department consistently ranked #1 in US News & World Report’s Survey of America’s Best Hospitals, this event is a prime opportunity for professionals dedicated to improving patient care and outcomes.